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We consider that in our case, the presence
of HHV-6 DNA in the myocardium, in the
absence of other pathogens, suggests
that the myocarditis was caused by the
virus. Moreover, we suggest that the identi-
fication of the viral genome is favourable to
a pathogenic relationship between the virus
and the cardiac anomaly.
In our case, there are pathological findings
of acute, subacute and chronic myocarditis
compatible with viral persistence. The
infection probably occurred early in the
second trimester of pregnancy. We postulate
that the virus-induced myocardial injury and
the subsequent reparative lesions in the
heart in development may be the cause of
structural cardiac defects in this fetus.
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In 1985 and 1988, Gerard Guillet and
Raymond Hélénon, with colleagues,
described a novel acquired hypopigmentation
disorder in dark-skinned immigrants from
the Caribbean which they named progressive
macular hypomelanosis (PMH).1 2 Over the
past 20 years, many other terms have been
coined for this condition, including cutis
trunci variata, nummular and confluent
hypomelanosis, Creole dyschromia, or idio-
pathic multiple large-macule hypomela-
nosis.3 More than 600 PMH patients have
been reported in the literature with skin
phototypes IIeVI, but the debate about the
aetiology of this disorder is still open.
We present an immunohistochemical and
ultrastructural study on disseminated PMH
extending beyond the trunk. No Propioni-
bacterium colonisation of skin was found
despite extensive examination. The
evidence for a bacterial origin is discussed in
consideration of the literature.
A 29-year-old Romanian female patient
(skin phototype III), who had relocated to
Germany 8 years earlier, presented with
a mottled hypopigmentation of her skin that
had progressed over the past 12 years. At
the age of 17, macules started to appear
on the abdomen and then spread gradually
to the flanks, axillae and back. Over the past
2 years, the patient had noticed a rapid
progression to the neck, décolleté and groin
without any subjective symptoms. Physical
examination revealed multiple partially
coalescing oval or irregular hypopigmented
macules ranging in diameter from 1 to 5 cm
without any scaling (figure 1A). There was
no fluorescence under illumination with
Wood’s light (figure 1B). Other family
members were not affected.
Blood tests including HIV-ELISA were
unremarkable with the exception of TPPA
(1:160). Standard bacterial cultures
(McConkey-sheep blood agar, 378C) fromskin
swabs revealed coagulase-negative Staphylo-
coccus aureus. Cultures under microaerophilic
and dark conditions on braineheart infusion
agar (pH 7.1, 378C) were negative for Propio-
nibacterium species. Treponema pallidum DNA
was not found after PCR in PMH lesion.
Take-home messages
< Despite congenital infection with HHV-
6 having an established prevalence of
1%, there are few reports associating
HHV-6 to disease in fetuses.
< HHV-6 has been implicated in myocar-
ditis in adults and children, but there
was no previous association with
myocarditis in fetuses.
< The virus-induced myocardial injury
and the subsequent reparative lesions
in the heart in development may be
the cause of structural cardiac defects
in fetuses.
Figure 1 (A) Disseminated progressive macular hypomelanosis in a 29-year-old female patient.
(B) No follicular fluorescence under Wood’s light (UVA 320e400 nm), right flank part.
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Amarked reduction of pigment in the basal
layer of the epidermis and a sparse lympho-
histiocytic infiltrate could be seen in lesional
skin on H&E (figure 2A) and Fontanae
Masson staining (figure 2B). Bacteria and
fungi were absent in both hair follicles
and inter-follicular epidermis on H&E or
periodic acid Schiff-stained sections. Melan
A staining showed normal melanocyte
morphology but reduced numbers in the
basal layer (figure 2C). Electron microscopy
revealed smaller and aggregated melano-
somes in the affected areas compared with
unaffected skin (figure 3).
Phototherapy was declined by the patient.
However, encouraged by a report from the
literature,4 we tried 2.5% benzoyl peroxide
cream treatment twice daily for a month
despite the lack of evidence of Propionibacte-
rium. We did not observe any effect after
6 months’ follow-up.
No consensus has been reached so far
regarding the aetiology of PMH. Based on
the observation of follicular red fluorescence
under Wood’s light in 50 from 291 PMH
patients, and isolates of Propionibacterium
from lesional, but not from healthy skin in
six patients, a bacterial aetiology for PMH
was proposed.5 This provided the rationale
for a randomised, within-patient, lefteright
comparison trial between topical antimicro-
bial treatment (5% benzoyl peroxide gel and
1% clindamycin lotion, bcUVA) and anti-
inflammatory treatment (0.05% fluticasone
cream, fUVA), both combined with UVA
three times/week for 14 weeks.4 Both treat-
ment arms achieved temporary repigmenta-
tion or hyperpigmentation. At the 12-week
examination, lesional (re)pigmentation was
found to approximate the pigmentation of
normal skin in both arms with a difference
of 0.9 colorimetric units. A complete repig-
mentation was observed only in 62% (28/45)
bcUVA- treated arms compared to 22%
(10/45) after fUVA at the 12-week follow-
up. The remaining sites showed either no or
incomplete repigmentation.4
The study leaves many questions unan-
swered: To what extent does the topical
treatment contribute to the effect of UVA?
Other studies employing only phototherapy
have demonstrated beneficial effects of
UVB6 or sun light.7 Could the lower degree
of pigmentation achieved in the fUVA arm
have been brought about by corticosteroid?
If the cause of PMH was an infection, why
would anti-inflammatory treatment be
effective as well? Why was the treatment
effect transient? To evaluate the efficacy of
antimicrobial therapy, treatment versus
placebo, vehicle plus UVA would have been
preferable.
Figure 2 Histological stains and immunohistochemistry of healthy (left) and lesional (right) skin
from the back: a marked reduction of pigment in the basal layer of the epidermis in lesional skin
(right) on (A) H&E and (B) FontanaeMasson staining; (C) a reduction in the number of melanocytes
in lesional skin (right) in Melan A staining.
Figure 3 Electron microscopy of healthy (left) and lesional (right) skin parts of the back; immature
melanosomes look smaller and aggregated in the lesional skin (320 000).
Take-home messages
< Progressive macular hypomelanosis
(PMH) is a rare aetiologically unknown
pigmentation anomaly characterised
by small, immature melanosomes
containing low-density melanin.
< The diagnosis of PMH is based on
the ultrastructural examination of
melanosomes.
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Why do acne patients, whose skin
is densely colonised by propionibacteria,
never exhibit signs of hypopigmentation or
PMH? One recent study identified Propioni-
bacterium species other than Propionibacterium
acnes from the skin of 8 out of 14 PMH
patients, where the remaining 6 patients
were found to harbour P acnes exclusively on
their skin.8 This definitely put the existence
of any causative or PMH-specific species in
doubt.
As reported earlier in this article,3 we did
not find any signs of Propionibacterium colo-
nisation of lesional skin by Wood’s light
examination, microbiological analysis or
pathology. The diagnosis of PMH was
confirmed by histology and electron micros-
copy. Other differential diagnosis of hypo-
pigmentation (syphilis, pityriasis versicolor,
pityriasis alba, leprosy, incontinentia pigmenti,
mycosis fungoides or arsenic hypomelanosis)
could be excluded by clinical signs, history,
laboratory and histopathology.
The follicularfluorescenceunderWood’s light
is obviously an indicator of Propionibacterium
colonisation, but the prevalence of these
bacteria has to be evaluated epidemiologically in
PMH patients and healthy controls. Our
observations as well as those of others3 show
that PMH occurs in the absence of Propioni-
bacterium. We therefore rather favour the
hypothesis of a genetic background of PMH as
proposed by Guillet et al2 with an impaired
melanosomal maturation process giving rise to
smaller melanosomes, containing low-density
melanin.
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